Dawn Sauro joined Sarah Cannon in 2015 as the President of Development Innovations, the full-service, oncology-focused contract research organization for Sarah Cannon.
Prior to joining Sarah Cannon, she served as Senior Vice President and General Manager, Hematology and Oncology at inVentiv Health Clinical. Prior to her tenure at inVentiv she was Vice President, Operations at PRA Health Sciences and served in leadership roles at PPD, Inc., Pfizer and Ingenix Pharmaceutical Services. Through her career, Dawn has gained cross-functional leadership experience, demonstrated strong team building skills and has supported numerous successful Oncology registration programs.
- 2018 Quality Congress: Operationalizing Risk-Based Approaches in Light of ICH E6 (R2) and a Focus on Inspection Preparedness Across the Entire Clinical Trial Ecosystem